Rasagiline Tablet
Product Images NDC 47781-683

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rasagiline (NDC 47781-683). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alvogen, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rasagiline 0pt5mg Label

Each tablet contains rasagiline mesylate equivalent to 0.5 mg rasagiline. Distributed by Alvogen, Inc. in Worristown, NJ, USA. Manufactured by OrBion Pharmaceuticals Private Limited in India. This product comes in a 30-tablet package of Sarvegen® tablets, with a dosage recommended in the associated prescribing information. The package features a child-resistant cap and should be stored at 20°C to 25°C. Keep out of reach of children. The M.L. No. is TNOD0D2222/2006.*

FDA Label Image

Rasagiline 1mg Label

Each tablet contains rasagiline mesylate equivalent to 0.1 mg rasagiline. Distributed by Alvogen, Inc., Morristown, NJ 07960, USA. Manufactured by Orion Pharmaceuticals Private Limited, Irungatiukotti - 602 117, India. Product of India. This package contains 30 Rasagiline tablets, a prescription drug. Dosage details are given in the accompanying prescribing information. It should be dispensed in a child-resistant container and kept tightly closed at room temperature. Keep it and all drugs out of the reach of children. The M.L No. and other details are not readable.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.